Tami Danielle Lieberman, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Burkholderia Infections | 3 | 2013 | 41 | 0.910 |
Why?
|
Staphylococcus epidermidis | 1 | 2024 | 121 | 0.880 |
Why?
|
Evolution, Molecular | 5 | 2024 | 1896 | 0.830 |
Why?
|
Burkholderia | 2 | 2013 | 35 | 0.820 |
Why?
|
Dermatitis, Atopic | 2 | 2023 | 737 | 0.610 |
Why?
|
Skin | 5 | 2024 | 4503 | 0.600 |
Why?
|
Acne Vulgaris | 1 | 2022 | 352 | 0.530 |
Why?
|
Selection, Genetic | 7 | 2024 | 877 | 0.510 |
Why?
|
Staphylococcal Infections | 2 | 2023 | 1398 | 0.470 |
Why?
|
Wound Healing | 1 | 2024 | 2809 | 0.410 |
Why?
|
DNA, Bacterial | 1 | 2016 | 1478 | 0.380 |
Why?
|
Bacteria | 4 | 2024 | 2216 | 0.360 |
Why?
|
Spleen | 1 | 2016 | 2295 | 0.350 |
Why?
|
Staphylococcus aureus | 4 | 2023 | 1430 | 0.330 |
Why?
|
Adaptation, Physiological | 3 | 2024 | 1312 | 0.290 |
Why?
|
Genes, Bacterial | 1 | 2011 | 1076 | 0.290 |
Why?
|
Phylogeny | 4 | 2020 | 2843 | 0.260 |
Why?
|
Mutation | 8 | 2024 | 30238 | 0.260 |
Why?
|
Mycobacterium tuberculosis | 1 | 2016 | 1930 | 0.250 |
Why?
|
Genome, Bacterial | 3 | 2024 | 796 | 0.250 |
Why?
|
Cystic Fibrosis | 2 | 2017 | 1294 | 0.250 |
Why?
|
Adaptation, Biological | 2 | 2019 | 147 | 0.240 |
Why?
|
Lymph Nodes | 1 | 2016 | 3474 | 0.240 |
Why?
|
Bacteroides | 1 | 2024 | 165 | 0.230 |
Why?
|
Tuberculosis | 1 | 2016 | 2029 | 0.220 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5863 | 0.210 |
Why?
|
Genetic Variation | 2 | 2016 | 6611 | 0.200 |
Why?
|
Acclimatization | 1 | 2022 | 113 | 0.200 |
Why?
|
Propionibacterium acnes | 1 | 2022 | 59 | 0.200 |
Why?
|
Symbiosis | 1 | 2024 | 297 | 0.190 |
Why?
|
Lung | 2 | 2017 | 10099 | 0.180 |
Why?
|
Liver | 1 | 2016 | 7577 | 0.180 |
Why?
|
Drug Resistance, Multiple, Bacterial | 2 | 2015 | 591 | 0.180 |
Why?
|
Probiotics | 1 | 2024 | 387 | 0.170 |
Why?
|
Anti-Bacterial Agents | 5 | 2016 | 7477 | 0.170 |
Why?
|
Bacteroides fragilis | 1 | 2019 | 250 | 0.140 |
Why?
|
Genomics | 3 | 2022 | 5926 | 0.140 |
Why?
|
Tuberculosis, Hepatic | 1 | 2016 | 2 | 0.140 |
Why?
|
Tuberculosis, Splenic | 1 | 2016 | 2 | 0.140 |
Why?
|
Stenotrophomonas maltophilia | 1 | 2017 | 18 | 0.140 |
Why?
|
Tropolone | 1 | 2016 | 10 | 0.140 |
Why?
|
Tetracycline Resistance | 1 | 2016 | 22 | 0.140 |
Why?
|
Monoterpenes | 1 | 2016 | 22 | 0.140 |
Why?
|
Tuberculosis, Lymph Node | 1 | 2016 | 21 | 0.140 |
Why?
|
Genome, Viral | 1 | 2020 | 674 | 0.140 |
Why?
|
Drug Resistance, Bacterial | 2 | 2016 | 1063 | 0.140 |
Why?
|
Disulfiram | 1 | 2016 | 63 | 0.130 |
Why?
|
Microbial Sensitivity Tests | 3 | 2016 | 1967 | 0.130 |
Why?
|
Bacteriological Techniques | 1 | 2016 | 277 | 0.120 |
Why?
|
Models, Genetic | 1 | 2024 | 3447 | 0.120 |
Why?
|
Genome | 1 | 2022 | 1754 | 0.110 |
Why?
|
Ciprofloxacin | 2 | 2016 | 313 | 0.110 |
Why?
|
Host-Pathogen Interactions | 2 | 2013 | 1469 | 0.110 |
Why?
|
Autopsy | 1 | 2016 | 1011 | 0.100 |
Why?
|
Gene Library | 1 | 2015 | 1064 | 0.100 |
Why?
|
Saccharomyces cerevisiae | 1 | 2023 | 2682 | 0.100 |
Why?
|
Burkholderia cepacia complex | 1 | 2012 | 24 | 0.100 |
Why?
|
Chloroplasts | 1 | 2011 | 46 | 0.090 |
Why?
|
Synechococcus | 1 | 2011 | 30 | 0.090 |
Why?
|
South Africa | 1 | 2016 | 1873 | 0.090 |
Why?
|
HIV Infections | 1 | 2016 | 17569 | 0.080 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2016 | 843 | 0.080 |
Why?
|
Escherichia coli Proteins | 1 | 2016 | 1058 | 0.080 |
Why?
|
Polysaccharides, Bacterial | 1 | 2012 | 582 | 0.080 |
Why?
|
Metabolic Networks and Pathways | 1 | 2013 | 801 | 0.080 |
Why?
|
Likelihood Functions | 1 | 2011 | 994 | 0.080 |
Why?
|
Virulence Factors | 1 | 2011 | 502 | 0.070 |
Why?
|
Humans | 13 | 2024 | 768166 | 0.070 |
Why?
|
Escherichia coli | 2 | 2016 | 4214 | 0.070 |
Why?
|
Disease Models, Animal | 2 | 2024 | 18349 | 0.060 |
Why?
|
Antibodies, Bacterial | 1 | 2012 | 1479 | 0.060 |
Why?
|
Epidemics | 1 | 2011 | 517 | 0.060 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22379 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2016 | 16045 | 0.060 |
Why?
|
Bacteremia | 1 | 2011 | 986 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10873 | 0.060 |
Why?
|
Lipopolysaccharides | 1 | 2011 | 2219 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3671 | 0.050 |
Why?
|
Lung Diseases | 1 | 2011 | 1944 | 0.050 |
Why?
|
Mice | 2 | 2024 | 82029 | 0.040 |
Why?
|
Child | 2 | 2023 | 80917 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2021 | 1049 | 0.040 |
Why?
|
Trimethoprim | 1 | 2016 | 79 | 0.030 |
Why?
|
Metagenomics | 1 | 2019 | 474 | 0.030 |
Why?
|
Microbial Viability | 1 | 2016 | 237 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2015 | 464 | 0.030 |
Why?
|
Animals | 3 | 2024 | 169246 | 0.030 |
Why?
|
Genetics, Population | 1 | 2019 | 944 | 0.030 |
Why?
|
Female | 4 | 2024 | 397192 | 0.030 |
Why?
|
Microbiology | 1 | 2013 | 70 | 0.030 |
Why?
|
Adult | 3 | 2019 | 223646 | 0.030 |
Why?
|
Citric Acid Cycle | 1 | 2013 | 234 | 0.030 |
Why?
|
Blood Bactericidal Activity | 1 | 2012 | 124 | 0.020 |
Why?
|
Molecular Structure | 1 | 2016 | 1883 | 0.020 |
Why?
|
Genotype | 2 | 2016 | 13045 | 0.020 |
Why?
|
Drug Therapy | 1 | 2014 | 504 | 0.020 |
Why?
|
Young Adult | 2 | 2019 | 60066 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1761 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3055 | 0.020 |
Why?
|
Photosynthesis | 1 | 2011 | 69 | 0.020 |
Why?
|
Biological Evolution | 1 | 2015 | 1076 | 0.020 |
Why?
|
Male | 3 | 2019 | 364719 | 0.020 |
Why?
|
Phenotype | 2 | 2016 | 16726 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9374 | 0.020 |
Why?
|
DNA Primers | 1 | 2011 | 2828 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 4860 | 0.020 |
Why?
|
Phagocytosis | 1 | 2012 | 1530 | 0.020 |
Why?
|
Plasmids | 1 | 2011 | 2269 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2011 | 936 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6316 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10760 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 4786 | 0.010 |
Why?
|
Aged | 1 | 2016 | 171504 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2011 | 81762 | 0.010 |
Why?
|
Middle Aged | 1 | 2016 | 223492 | 0.010 |
Why?
|
Base Sequence | 1 | 2011 | 12421 | 0.010 |
Why?
|
Zebrafish | 1 | 2011 | 3035 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2011 | 3840 | 0.010 |
Why?
|
DNA | 1 | 2011 | 7214 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54926 | 0.010 |
Why?
|
Macrophages | 1 | 2011 | 5799 | 0.010 |
Why?
|
Immunotherapy | 1 | 2012 | 4755 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 40218 | 0.010 |
Why?
|